The role of somatostatin (octreotide) in the regulation of melatonin secretion in healthy volunteers and in patients with primary hypothyroidism

Journal of Endocrinological Investigation

Volumn 22, Issue 7, 1999, Pages 527-534

  Wikner, Johan ^a   Wetterberg, L ^b   Rojdmark S ^a  

^a STOCKHOLM SÖDER HOSPITAL   (Sweden)

^b ST GÖRAN S HOSPITAL   (Sweden)

Author keywords

GH; Hypothyroidism; Melatonin; Octreotide; Pineal gland; Somatostatin; Somatotropin; TSH

Indexed keywords

LIOTHYRONINE; MELATONIN; OCTREOTIDE; SOMATOSTATIN; THYROXINE;

ARTICLE; CLINICAL ARTICLE; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; FEMALE; HORMONE RELEASE; HUMAN; HYPOTHYROIDISM; LIOTHYRONINE BLOOD LEVEL; PINEAL BODY; PINEALOCYTE; RANDOMIZED CONTROLLED TRIAL; SUBCUTANEOUS DRUG ADMINISTRATION; THYROXINE BLOOD LEVEL; URINARY EXCRETION;

EID: 0032832559     PISSN: 03914097     EISSN: None     Source Type: Journal    
DOI: 10.1007/BF03343604     Document Type: Article

References (30)

1. Reiter R.J. Pineal melatonin: cell biology of its synthesis and of its physiologic interactions. Endocr. Rev. 1991, 12: 151-180.
2. Yu H.-S., Tsin A.T.C., Reiter R.J. Melatonin: History, Biosynthesis and Assay Methodology. In: Yu H.-S., Reiter R.J. (Eds.), Melatonin. Biosynthesis, Physiological Effects, and Clinical Applications. CRC Press Ann Arbor, 1993, pp. 495-512.
3. Sugden D., Van Camp G. Rat pineal α1-adrenoceptors: physiological importance and identification of subtypes. Adv. Pineal Res. 1994, 8: 189-196.
4. Sugden A.L., Sugden D., Klein D.C. Essential role of calcium influx in the adrenergic regulation of cAMP and cGMP in rat pinealocytes. J. Biol. Chem. 1986, 267: 11608-11612.
5. Ou C.Z., Ebadi M. Pineal and retinal protein kinase C isoenzymes: Cooperative activation by calcium and zinc metallothionein. J. Pineal Res. 1992, 12: 17-26.
6. Brismar K., Werner S., Bucht E., Wetterberg L. Melatonin, cortisol, prolactin, and calcitonin secretion in primary hyperparathyroidism before and after surgery. J. Pineal Res. 1987, 4: 277-285.
7. Wikner J., Wetterberg L., Röjdmark S. Does hypercalcemia or calcium antagonism affect human melatonin secretion or renal excretion? Eur. J. Clin. Invest. 1997, 27: 374-379.
8. Röjdmark S., Wetterberg L. Short-term fasting inhibits the nocturnal melatonin secretion in healthy man. Clin. Endocrinol. 1989, 30: 451-457.
9. Brazeau P., Vale W., Burgus R. Hypothalamic polypeptide that inhibits the secretion of immunoreactive pituitary growth hormone. Science 1973, 179: 77-79.
10. Brownstein M., Arimura A., Sato H., Schally A.V., Kizer J.S. The regional distribution of somatostatin in the rat brain. J. Endocrinol. 1975, 96: 1456-1461.
11. Webb S.M., Peinado M.-A., Puig-Domingo M., Viader M., Reiter R.J. Rhythms in pineal immunoreactive somatostatin in the syrian hamster, mouse and gerbil. J. Pineal Res. 1988, 5: 273-278.
12. Peinado M.A., Viader M., Puig-Domingo M., Webb S.M., Reiter R.J. Regional distribution of immunoreactive somatostatin in the bovine pineal gland. Neuroendocrinology 1989, 50: 550-554.
13. Fodor M., Slama A., Guillaume V., Videau C., Csaba Z., Oliver C., Epelbaum J. Distribution and pharmacological characterization of somatostatin receptor binding sites in the sheep brain. J. Chem. Neuroanat. 1997, 12: 175-182.
14. Röjdmark S., Berg A., Rössner S., Wetterberg L. Nocturnal melatonin secretion in thyroid disease and in obesity. Clin. Endocrinol. 1991, 35: 61-65.
15. Bauer W., Briner U., Doepfner W., Haller R., Huguenin R., Marbach P. SMS-201-995: A very potent and selective octapeptide analogue of somatostatin with prolonged action. Life Sci. 1982, 37: 1133-1140.
16. Wetterberg L., Eriksson O., Friberg Y., Vangbo B. A simplified radio-immunoassay for melatonin and its application to biological fluids. Preliminary observations on the half-life of plasma melatonin in man. Clin. Chim. Acta 1978, 86: 169-177.
17. Siggaard-Andersen O., Thode J., Wandrup J. The concentration of free calcium ions in plasma. Copenhagen: Radiometer A/S, Denmark 1980 ISSN 0906-0189; 163-190.
18. Krentz A.J., Boyle P.J., Macdonald L.M., Schade D.S. Octreotide: a long-acting inhibitor of endogenous hormone secretion for human metabolic investigation. Metabolism 1994, 43: 24-31.
19. Shulkes A. Somatostatin: physiology and clinical applications. Clin. Endocrinol. Metab. 1994, 8: 215-236.
20. Anton-Tay F., Diaz J.L., Femandez-Guardiola G. On the effects of melatonin upon human brains: Its possible therapeutic implications. Life Sci. 1971, 70: 841-850.
21. Vollrath L., Semm P., Gammel G. Sleep induction by intranasal application of melatonin. Adv. Biosci. 1981, 29: 327-329.
22. Frieboes R.M., Murck H., Schier T., Holsboer F., Steiger A. Somatostatin impairs sleep in elderly human subjects. Neuropsychopharmacology 1997, 76: 339-345.
23. Lang U., Kornemark M., Aubert M.L., Paunier L., Sizonenko P.C. Radioimmunological determination of urinary melatonin in humans: correlation with plasma levels and typical 24 hour rhythmicity. J. Clin. Endocrinol. Metab. 1981, 53: 645-650.
24. Chernausek S.L., Turner R. Attenuation of spontaneous, nocturnal growth hormone secretion in children with primary hypothyroidism and its correlation with plasma insulin-like growth factor I concentrations. J. Pediatr. 1989, 174: 968-972.
25. Fernandez B., Malde J.L., Montero A., Acuna D. Relationship between adenohypophyseal and steroid hormones and variations in serum and urinary melatonin levels during the ovarian cycle, perimenopause and menopause in healthy women. J. Steroid Biochem. 1990, 35: 257-262.
26. Rodriguez F., Jolin T. The role of somatostatin and/or dopamine in basal and TRH-stimulated TSH release in food-restricted rats. Acta Endocrinol. 1991, 725: 186-191.
27. Murao K., Takahara J., Sato M., Tamaki M., Niimi M., Ishida T. Relationship between thyroid functions and urinary growth hormone secretion in patients with hyper-and hypothyroidism. Endocr. J. 1994, 41: 517-522.
28. Lucke C., Höffken B., von zur Mühlen A. The effect of somatostatin on TSH levels in patients with primary hypothyroidism. J. Clin. Endocrinol. Metab. 1975, 41: 1082-1084.
29. Lucarotti M.E., Hamilton J.A., Farndon J.R. Somatostatin and primary hyperparathyroidism. Br. J. Surg. 1994, 87: 1141-1143.
30. Sinisi A.A., Pasquali D., D'Apuzzo A., Esposito D., Venditto T., Criscuolo T., De Bellis A., Bellastella A. Twenty-four hour melatonin pattern in acromegaly: Effect of acute octreotide administration. J. Endocrinol. Invest. 1997, 20: 128-133.